| Marilyn Weigner, MD | |
|
450 Veterans Memorial Pkwy, Building 15, East Providence, RI 02914-5300 | |
| (401) 228-2024 | |
| (401) 228-2026 |
| Full Name | Marilyn Weigner |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 450 Veterans Memorial Pkwy, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376561282 | NPI | - | NPPES |
| 9003694 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD09756 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
| The Miriam Hospital | 6901796408 | 186 |
News Archive
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.
In this globalhealthpolicy.net blog post, Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, examines funding for the World Health Organization, highlighting two documents circulated as background reading for the just-concluded World Health Assembly.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Every year, more than 300,000 student-athletes sustain sports-related head injuries. With the fall sports season just around the corner, this is a startling statistic for parents who worry about the devastating effects concussions can have on their children.
› Verified 3 days ago
| Entity Name | The Miriam Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851677470 PECOS PAC ID: 6901796408 Enrollment ID: O20120416000473 |
News Archive
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.
In this globalhealthpolicy.net blog post, Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, examines funding for the World Health Organization, highlighting two documents circulated as background reading for the just-concluded World Health Assembly.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Every year, more than 300,000 student-athletes sustain sports-related head injuries. With the fall sports season just around the corner, this is a startling statistic for parents who worry about the devastating effects concussions can have on their children.
› Verified 3 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.
In this globalhealthpolicy.net blog post, Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, examines funding for the World Health Organization, highlighting two documents circulated as background reading for the just-concluded World Health Assembly.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Every year, more than 300,000 student-athletes sustain sports-related head injuries. With the fall sports season just around the corner, this is a startling statistic for parents who worry about the devastating effects concussions can have on their children.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marilyn Weigner, MD 450 Veterans Memorial Pkwy, Building 15, East Providence, RI 02914-5300 Ph: (401) 228-2024 | Marilyn Weigner, MD 450 Veterans Memorial Pkwy, Building 15, East Providence, RI 02914-5300 Ph: (401) 228-2024 |
News Archive
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe.
In this globalhealthpolicy.net blog post, Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, examines funding for the World Health Organization, highlighting two documents circulated as background reading for the just-concluded World Health Assembly.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
Every year, more than 300,000 student-athletes sustain sports-related head injuries. With the fall sports season just around the corner, this is a startling statistic for parents who worry about the devastating effects concussions can have on their children.
› Verified 3 days ago
Matthew J Franco, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave, Suite 401, East Providence, RI 02914 Phone: 800-508-4908 Fax: 401-228-6236 | |
Mr. Michael F Gilson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, 2nd Floor, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Christopher Song, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Ricardo Rafael Correa Marquez, M.D Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 900 Warren Avenue, Suite 300, East Providence, RI 02914 Phone: 786-246-5719 | |
May Min, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave Ste 301, East Providence, RI 02914 Phone: 401-606-4260 | |
Prerna Ganjoo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 | |
Mordecai Jeremiah Stolk, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 |